Publications by the researcher in collaboration with Raquel Marzoa Rivas (45)

2021

  1. Economic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1055-1062

2020

  1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437

  2. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 652-659

  3. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 1, pp. 92-102

  4. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389

2019

  1. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352

  2. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2017

  1. Prognostic Value of the Nutritional Risk Index in Heart Transplant Recipients

    Revista Espanola de Cardiologia, Vol. 70, Núm. 8, pp. 639-645

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

  2. Estado serológico frente a Toxoplasma gondii en receptores de trasplante cardiaco: ¿un factor pronóstico independiente?

    Revista Espanola de Cardiologia, Vol. 69, Núm. 12, pp. 1160-1166

  3. Utilidad de una herramienta educativa sencilla (4 fichas de colores) y evaluación de la satisfacción de los pacientes

    XX Encuentro Internacional de Investigación en Cuidados

2015

  1. Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: A single-center experience

    Transplantation Proceedings

  2. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: Short-term and long-term efficacy and safety results

    Transplant International, Vol. 28, Núm. 9, pp. 1034-1041

  3. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  4. Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42

  5. Significado pronóstico y evolución a largo plazo de la frecuencia cardiaca en los pacientes con trasplante cardiaco

    Revista Espanola de Cardiologia, Vol. 68, Núm. 11, pp. 943-950

  6. Venous thromboembolism in heart transplant recipients: Incidence, recurrence and predisposing factors

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 2, pp. 167-174

2014

  1. Antibody-mediated rejection: Analyzing the risk, proposing solutions

    Transplantation, Vol. 98, Núm. SUPPL. 3

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184